Abstract:Genetics is estimated to account for 50% of Coronary Artery Disease (CAD) risk. Genome-Wide Association Studies (GWAS) have revealed 100s of genomic loci which are associated with CAD (1). However, moving from GWAS signals to causal genes has proved challenging, slowing progress in developing interventions for CAD and other diseases. The greatest challenge in interpreting GWAS data is that only 10% of variants are in protein-coding regions and 90% are in "non-coding" genomic regions. Many of these non-coding variants are found in regulatory elements such as enhancers. Enhancers are distal regulatory elements that bind transcription factors and regulate genes up to 1 million base pairs away. This is achieved by DNA looping bringing enhancers into physical proximity with target genes. However, it is not possible to predict which gene(s) a given enhancer will regulate based on genomic location alone. We aimed to develop a generalisable workflow to solve CAD GWAS signals accurately and sensitively, by identifying causal enhancer SNPs and linking them mechanistically to output genes in a cell-type specific manner. We combined cell-specific epigenomic mapping with machine learning to prioritise 21,959 SNPs from 861 candidate CAD loci, in endothelial cells (HUVECs) and smooth muscle cells (HCASMCs). Micro-Capture-C (MCC) was used to resolve enhancer-promoter interactions at base-pair resolution (2). MNase footprinting determined differential transcription factor binding at specific enhancer SNPs. In HCASMCs, 20 putative enhancers containing CAD SNPs were found to interact with 32 genes, and in HUVECs 25 enhancers interacted with 48 genes. These genes were enriched for pathways including TGFb signalling, RUNX3 activity, and MAPK6/MAPK4 signalling. To prove causality at specific loci, heterozygous SNPs were identified in the individual primary cell lines. The interaction frequency at these elements was statistically compared between risk and non-risk alleles. For example, at the 9p21.3 locus, an enhancer containing a non-risk T allele was found to interact more strongly with the CDKN2B gene, compared to the risk G allele. Interestingly, this imbalance between allele interaction was potentiated by stimulation with TGFb, a key mediator in atherosclerosis. Furthermore, the transcription factor footprint at the SNP location was altered by the risk allele, indicating the mechanistic cause of the CAD-associated change in CDKN2B expression. We demonstrate a combined computational and experimental approach to identify causal non-coding variants in CAD risk loci, at scale. Among the key outputs of this study is the identification of the risk variant (rs1537373), output gene (CDKN2B), and specific cell type (HCASMC) underlying the 9p21.3 locus association with CAD risk. Using this approach to translate GWAS signals into cell-type specific outputs genes, will lead to a better understanding of the pathogenesis of CAD, and new therapeutic opportunities.

Abstract 12513: Post-GWAS Functional Analysis of the CDKN2A/B Locus Identifies CUX1 As a Regulator of Endothelial Senescence by Modulating the CAD-Associated P16 INK4A Expression

Post-GWAS Functional Analysis Identifies CUX1 As a Regulator of P16 INK4a and Cellular Senescence

Post-GWAS functional analysis identifies CUX1 as a regulator of p16INK4a and cellular senescence

SATB2, coordinated with CUX1, regulates IL‐1β‐induced senescence‐like phenotype in endothelial cells by fine‐tuning the atherosclerosis‐associated p16INK4a expression

Cathepsin L induces cellular senescence by upregulating CUX1 and p16INK4a

Nuclear Factor Kappa-B/Homeobox A9-Mediated Modulation of Leucine-Rich Repeat Flightless-Interacting Protein 1 Is Involved in Advanced Glycation End Product-Induced Endothelial Dysfunction

Abstract 10314: Post-GWAS Functional Genomics Analysis of CBLN2 Locus to Define the Pathogenic Role of CUX1 in Pulmonary Arterial Hypertension

Genome-Wide Search Links Senescence-Associated Secretory Proteins With Susceptibility for Coronary Artery Disease in Mouse and Human

Cyclin-dependent Kinase Inhibitor P16ink4a and Telomerase May Co-Modulate Endothelial Progenitor Cells Senescence

Abstract 75: CTCF and Rad21 Mediated Regulation of Gene Expression in Human-Induced Pluripotent Stem Cells-derived Endothelial Cells

CDKN1A As a Target of Senescence in Heart Failure: Insights from a Multiomics Study

Bioinformatics-based Identification and Validation of Hub Genes Associated with Aging in Patients with Coronary Artery Disease.

Micro-capture-C in vessel wall cell types identifies mechanisms underlying coronary artery disease susceptibility loci

The orchestration of coding and non-coding genes at the CDH13 locus in coronary artery disease

Down-regulated RGS5 by Genetic Variants Impairs Endothelial Cell Function and Contributes to Coronary Artery Disease.

Identification of Key Biomarkers of Endothelial Dysfunction in Hypertension with Carotid Atherosclerosis Based on WGCNA and the LASSO Algorithm

Abstract 101: Genetic Ablation Of CCDC92 Protects Against Vascular Inflammation And Atherosclerosis

Trans-interaction of risk loci 6p24.1 and 10q11.21 is associated with endothelial damage in coronary artery disease

Comprehensive analysis of gene signatures associated with aging in human aortic dissection

The Novel Coronary Artery Disease Risk Gene JCAD/KIAA1462 Promotes Endothelial Dysfunction and Atherosclerosis.

Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells.